NASDAQ: RCKTRocket Pharmaceuticals Inc Stock Ownership - Who owns Rocket Pharmaceuticals?
Insider buying vs selling
Have Rocket Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Elisabeth Bjork | Director | 2025-08-27 | 10,000 | $3.41 | $34.10kBuy |
| Martin Wilson | General Counsel | 2025-08-19 | 588 | $3.00 | $1.76kSell |
| John Militello | Vice President of Finance Treasurer Principal Accounting Officer | 2025-08-19 | 361 | $3.00 | $1.08kSell |
| Jonathan David Schwartz | Chief Medical Gene Therapy Officer | 2025-08-19 | 805 | $3.00 | $2.41kSell |
| Jonathan David Schwartz | Chief Medical Gene Therapy Officer | 2025-08-18 | 1,680 | $3.07 | $5.15kSell |
| John Militello | Vice President of Finance Treasurer Principal Accounting Officer | 2025-08-18 | 699 | $3.07 | $2.14kSell |
| Gaurav Shah | CEO | 2025-08-18 | 2,234 | $3.05 | $6.81kSell |
| Martin Wilson | General Counsel | 2025-08-18 | 1,004 | $3.07 | $3.08kSell |
| Jonathan David Schwartz | Chief Medical Gene Therapy Officer | 2025-08-14 | 11,161 | $3.02 | $33.70kSell |
| John Militello | Vice President of Finance Treasurer Principal Accounting Officer | 2025-08-14 | 7,043 | $3.02 | $21.26kSell |
RCKT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when RCKT insiders and whales buy or sell their stock.
RCKT Shareholders
What type of owners hold Rocket Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Roderick Wong | 31.98% | 34,508,759 | $111.12M | Insider |
| Rtw Investments LP | 31.16% | 33,617,724 | $108.25M | Insider |
| Rtw Investments LP | 16.39% | 17,687,772 | $56.95M | Institution |
| Maverick Capital Ltd | 7.75% | 8,363,813 | $26.93M | Institution |
| Blackrock Inc | 6.88% | 7,428,676 | $23.92M | Institution |
| Vanguard Group Inc | 5.67% | 6,122,461 | $19.71M | Institution |
| Suvretta Capital Management LLC | 3.84% | 4,143,333 | $13.34M | Institution |
| Mpm Bioimpact LLC | 3.62% | 3,903,081 | $12.57M | Institution |
| Devon Park Associates LP | 3.02% | 3,253,566 | $10.48M | Insider |
| Devon Park Bioventures LP | 3.01% | 3,243,709 | $10.44M | Insider |
RCKT vs Biotech Stocks
Rocket Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.